2026 article

Cerebral Edema in Patients With Large Ischemic Core After Thrombectomy: A Secondary Analysis of SELECT2 Randomized Trial

Felix Ng, Vignan Yogendrakumar, Hannah Tabitha Johns, Leonid Churilov, A Hassan, Michael G. Abraham, Santiago Ortega‑Gutierrez, M. Shazam Hussain, Michael Chen, Clark W. Sitton, Scott E. Kasner, Gagan Sharma, Prodipta Guha, Deep Kiritbhai Pujara, Vitor Mendes Pereira, Maarten G. Lansberg, Lawrence R. Wechsler, Thanh N. Nguyen, Johanna T. Fifi, Michael D. Hill, Marc Ribo, Mark W. Parsons, Stephen M. Davis, James Grotta, Gregory W. Albers, Bruce C.V. Campbell, Amrou Sarraj, for the SELECT2 Investigators

2Citations signalées, ce qui n’est pas une note de qualité

21Institutions déclarées

4Pays d’affiliation déclarés

Rattachement africain : au, us, ca, es. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

BACKGROUND: Cerebral edema is a life-threatening complication of ischemic stroke that disproportionally affects patients with large established infarction. We assessed whether endovascular thrombectomy (EVT) reduces or exacerbates edema development, and the association between edema with short-term and long-term outcomes in this high-risk population. METHODS: In this prespecified secondary analysis of the SELECT2 randomized clinical trial (Randomized Controlled Trial to Optimize Patient’s Selection for Endovascular Treatment in Acute Ischemic Stroke), which tested the efficacy and safety of EVT versus medical management in adult patients with acute anterior circulation large vessel occlusion presenting with large ischemic core (defined as Alberta Stroke Program Early Computed Tomography Score of 3–5 or core volume ≥50 mL on computed tomography perfusion or diffusion magnetic resonance imaging), we assessed maximum midline shift (MLS) within 7 days of randomization between treatment groups using a probabilistic index model. RESULTS: After exclusion of 10 patients who underwent hemicraniectomy before follow-up imaging, 342 patients were analyzed. The median MLS on follow-up magnetic resonance imaging or computed tomography was 6.39 mm (interquartile range, 0–12.0) in the EVT and 4.18 mm (interquartile range, 0–9.66) in medical management patients ( P =0.021). EVT was independently associated with greater MLS (adjusted odds ratio, 1.63 [95% CI, 1.25–2.12]; P =0.0027) after adjusting for age and core volume. There was no interaction between EVT and core volume at presentation on the association with MLS ( P >0.79). MLS was associated with the development of early neurological worsening (adjusted odds ratio, 1.15 [95% CI, 1.07–1.23]; P <0.001), and a lower likelihood of long-term functional improvement assessed on modified Rankin Scale score at 90 days (adjusted odds ratio, 0.96 [95% CI, 0.93–0.98]; P =0.0029). On mediation analysis, cerebral edema reduced the effect of EVT on functional outcome by 10.6%. CONCLUSIONS: Despite overall clinical benefit, EVT in patients presenting with a large ischemic core was associated with increased cerebral edema, which, in turn, was associated with early neurological worsening and worse functional outcome at 90 days. Early recognition and individualized treatment to prevent secondary injury from cerebral edema in this population are warranted. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03876457.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref: Cerebral Edema in Patients With Large Ischemic Core After Thrombectomy: A Secondary Analysis of SELECT2 Randomized Trial
Date Crossref: 01/06/2026
Éditeur: Ovid Technologies (Wolters Kluwer Health)
Type: journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

The Royal Melbourne Hospital Department of Neurology pays non établi dans la notice
Organisme public
The University of Melbourne Department of Medicine pays non établi dans la notice
Université ou école supérieure
Valley Baptist Medical Center pays non établi dans la notice
Établissement de santé
University of Kansas Medical Center Department of Neurology and Radiology pays non établi dans la notice
Organisme public
University of Iowa Department of Neurology pays non établi dans la notice
Université ou école supérieure
Cleveland Clinic Department of Neurology pays non établi dans la notice
Établissement de santé
Rush University Medical Center Department of Neurosurgery pays non établi dans la notice
Établissement de santé
The University of Texas Health Science Center pays non établi dans la notice
Université ou école supérieure
University of Pennsylvania Division of Vascular Neurology pays non établi dans la notice
Université ou école supérieure
Case Western Reserve University Department of Neurology pays non établi dans la notice
Université ou école supérieure
St. Michael's Hospital Division of Neurology pays non établi dans la notice
Établissement de santé
Stanford University Department of Neurology pays non établi dans la notice
Université ou école supérieure

Department of Neurology — The Royal Melbourne Hospital, Department of Medicine — The University of Melbourne et Valley Baptist Medical Center, avec 9 autres affiliations.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Acute Ischemic Stroke ManagementIntracerebral and Subarachnoid Hemorrhage ResearchPeripheral Artery Disease Management

Consulter la publication primaire Ouvrir le DOI